XML 109 R91.htm IDEA: XBRL DOCUMENT v3.25.0.1
Commitments and Contingencies - Contingencies - Additional Information (Detail)
€ in Millions
 1 Months Ended 12 Months Ended
Oct. 10, 2024
USD ($)
Jun. 14, 2024
USD ($)
Nov. 09, 2022
USD ($)
Jun. 02, 2022
USD ($)
Feb. 01, 2018
USD ($)
Sep. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Nov. 30, 2022
USD ($)
Feb. 28, 2021
USD ($)
Jul. 31, 2014
USD ($)
Sep. 30, 2013
USD ($)
Apr. 30, 2013
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Mar. 28, 2024
USD ($)
Aug. 21, 2023
USD ($)
Jul. 08, 2021
USD ($)
Mar. 31, 2021
EUR (€)
Dec. 20, 2020
USD ($)
Nov. 30, 2020
EUR (€)
Aug. 31, 2019
USD ($)
Feb. 29, 2012
USD ($)
Jul. 31, 2008
USD ($)
Commitment And Contingencies [Line Items]                                                
Annual sales at the time of settlement                                       $ 700,000,000   $ 350,000,000    
Annual sales of Effexor                         $ 2,600,000,000                      
Annual sales of Lamictal                                             $ 950,000,000 $ 2,300,000,000
Annual sales of Niaspan                     $ 1,100,000,000 $ 416,000,000                        
Litigation settlement amount             $ 4,250,000,000             $ 495,000,000                    
Litigation settlement amount awarded distribution period             13 years                                  
Generic modafinil, and imposed fines amount                           4,881,000,000 $ 4,771,000,000           € 60.5      
Loss Contingency Accrual, Provision                   $ 235,500,000                            
Annual sales of the time of settlement of viread                 $ 582,000,000                              
Annual sales of the time of settlement of Truvada                 2,400,000,000                              
Annual sales of the time of settlement of Atripla                 2,900,000,000                              
Annual sales of the time of New launch of viread                 728,000,000                              
Annual sales of the time of New launch of Truvada                 2,100,000,000                              
Annual sales of the time of New launch of Atripla                 $ 444,000,000                              
Litigation Settlement Amount Distributable In Kind             $ 1,200,000,000                                  
Accrual for Environmental Loss Contingencies                           $ 300,000                    
Loss Contingencies On Environmental Laws Penalty                                   $ 1,400,000            
Litigation fine amount of copaxone | €                                     € 462.6          
Litigation Settlement amount payable year one           $ 35,000,000                                    
Litigation settlement amount payable remainder of fiscal year           80,000,000                                    
Other commitment                               $ 150,000,000                
Annual Sales Of Revlimid               $ 3,500,000,000                                
Annual Sales At The Time Of Nuvigil Entered Into First Settlement Of With AN ANDA Filer   $ 300,000,000                                            
Loss Contingency Claims Dismissed Value Paid To Each State Proportional To Its Share Of National Population                             $ 1,000,000,000,000                  
Percentage Of Share Of The National Population                             1.00%                  
Percentgae of amount in cash settlement             20.00%                                  
Litigation Settlement Amount Distributable in cash             $ 240,000,000                                  
Loss Contingency, Damages Awarded, Value     $ 176,500,000                                          
Deferred Prosecution Agreement With U.S. Department of Justice [Member] | Donation of Clotrimazole and Tobramycin [Member]                                                
Commitment And Contingencies [Line Items]                                                
Other commitment                                 $ 50,000,000              
Deferred Prosecution Agreement With U.S. Department of Justice [Member] | Fine for Violating the Antitrust Laws [Member]                                                
Commitment And Contingencies [Line Items]                                                
Other commitment, to be paid, year five                                 135,000,000              
Other commitment to pay for each year                                 22,500,000              
Other commitment                                 $ 225,000,000              
Opioid Litigation [Member]                                                
Commitment And Contingencies [Line Items]                                                
Loss contingency accrual, product liability, undiscounted, to be paid, year five             385,000,000                                  
Loss contingency accrual, product liability, undiscounted, to be paid, year four             364,000,000                                  
Loss contingency accrual, product liability, undiscounted, to be paid, year three             363,000,000                                  
Loss contingency accrual, product liability, undiscounted, to be paid, year two             423,000,000                                  
Loss contingency accrual, product liability, undiscounted, to be paid, year one             $ 428,000,000                                  
Modafinil Settlement Agreement [Member]                                                
Commitment And Contingencies [Line Items]                                                
Settlement as a percentage of aggregate subdivisions and tribes             100.00%                                  
Civil Action In Respect Of Donations To Patient Assistance Programmers [Member]                                                
Commitment And Contingencies [Line Items]                                                
Generic modafinil, and imposed fines amount $ 425,000,000                                              
Loss contingency accrual due in fifth year 175,000,000                                              
Loss contingency accrual due in fourth year 99,000,000                                              
Loss contingency accrual due in third year 49,000,000                                              
Loss contingency accrual due in second year 49,000,000                                              
Loss contingency accrual next twelve months 34,000,000                                              
Loss contingency accrual remainder of fiscal year 19,000,000                                              
Civil Investigative Demand From Department Of Justice Civil Division [Member]                                                
Commitment And Contingencies [Line Items]                                                
Generic modafinil, and imposed fines amount 25,000,000                                              
Loss Contingency Accrual, Provision 25,000,000                                              
Civil Investigative Demand From Department Of Justice Civil Division [Member] | Two Thousand And Twenty Five [Member]                                                
Commitment And Contingencies [Line Items]                                                
Loss contingency accrual current 15,000,000                                              
Civil Investigative Demand From Department Of Justice Civil Division [Member] | Two Thousand And Twenty Four [Member]                                                
Commitment And Contingencies [Line Items]                                                
Loss contingency accrual current $ 10,000,000                                              
Ontario Teachers Securities Litigation [Member] | Settled Litigation [Member]                                                
Commitment And Contingencies [Line Items]                                                
Litigation settlement amount       $ 420,000,000                                        
Litigation With US Hospitals And Other Healthcare Providers [Member]                                                
Commitment And Contingencies [Line Items]                                                
Litigation settlement amount           $ 126,000,000                                    
Litigation settlement amount awarded distribution period           18 years                                    
Product WAC Value           $ 49,000,000                                    
Product WAC Term           7 years                                    
Europe [Member]                                                
Commitment And Contingencies [Line Items]                                                
Damage claimed         $ 50,000,000                                      
Eosinophilic Esophagitis [Member]                                                
Commitment And Contingencies [Line Items]                                                
Damage claimed         200,000,000                                      
Eosinophilic Esophagitis [Member] | United States [Member]                                                
Commitment And Contingencies [Line Items]                                                
Damage claimed         $ 150,000,000                                      
AndroGel Rate at 1% [Member]                                                
Commitment And Contingencies [Line Items]                                                
Annual sales at the time of settlement                                           $ 140,000,000